Abeona Therapeutics Inc.
ABEO
$6.89
$0.030.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,369.52% | 61.91% | 43.99% | -155.74% | 144.47% |
| Total Depreciation and Amortization | 12.12% | 12.57% | 7.63% | -3.86% | -18.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -520.24% | -119.68% | -174.84% | 487.74% | -367.39% |
| Change in Net Operating Assets | 539.42% | -21.48% | -477.93% | -107.53% | 177.64% |
| Cash from Operations | -48.09% | -26.58% | -79.31% | -112.91% | -23.34% |
| Capital Expenditure | -308.02% | -93.24% | -1,537.84% | -818.18% | -2,121.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -89.94% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 465.54% | 179.16% | 68.69% | 69.19% | -957.80% |
| Cash from Investing | 453.23% | 153.90% | 63.73% | 67.10% | -946.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.75% | 5.95% | -29.19% | -100.00% | 1,012.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.14% | 96.83% | 37.62% | -7,375.00% | -180.00% |
| Cash from Financing | -85.76% | -73.40% | -28.83% | -101.30% | 1,013.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 775.02% | -340.55% | -21.82% | -1,135.96% | 991.78% |